Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US industry more sure than Congress on Central America pact trade benefits

This article was originally published in Clinica

Executive Summary

The US device industry is applauding the passage of the controversial Central American Free Trade Agreement (CAFTA), which will allow US manufacturers to sell goods tariff-free in the Dominican Republic and five Central American countries. The Republican-controlled House approved the trade pact by a razor thin 217-215 margin on July 27. Only 15 of the 202 Democratic members voted for CAFTA - the smallest number ever for a trade agreement. 27 Republicans voted against it. Under CAFTA, 98% of US exports to the six nations will receive duty-free status.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT055978

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel